The company
Schrodinger, Inc.
SDGR · Nasdaq
SDGR stood above a rising 150-day average in 8 of the last 52 weekly readings, including each of the last 8 weeks. It is 34.9% above that average now. Life Science Tools & Research Services: 54% of its 79 stocks in an uptrend (+4 points in four weeks); Health Care: 26% (−10 points in four weeks).
Statistics
- Rotation
- In trend
- Weeks in an uptrend
- 8 in a row
- Industry in uptrend
- 54% +4 in 4 wk
- Insider buys, 12 months
- $0
- Insider sales, 12 months
- $4.6M
- Officials’ trades on record
- 3
- Institutions holding
- 214 (+10)
In the rotation
Each square a week: lit when it closed above a rising 150-day average. 8 of 52 weeks.
Life-science tools: About half its stocks are in an uptrend and the share has been climbing. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.
Money in and out
Open-market buys above the line and sales below, in dollars.
Congress and officials
3 disclosed lines: House 0, Senate 0, executive 3; 1 people.
| Who | Did | Amount | Traded |
|---|---|---|---|
| Donald J. Trump Executive branch: Office of Government EthicsWhite House Office | bought | $15k–$50k | 30 Mar 2026filed 14 May 2026 |
| Donald J. Trump Executive branch: Office of Government EthicsWhite House Office | sold | $15k–$50k | 26 Feb 2026filed 14 May 2026 |
| Donald J. Trump Executive branch: Office of Government EthicsWhite House Office | bought | $15k–$50k | 26 Jan 2026filed 14 May 2026 |
Insiders
| Who | Did | Shares | Traded |
|---|---|---|---|
| Karen AkinsanyaOfficer | sold | 10,000at $28.00 | 17 Sep 2026filed 21 Sep 2026 |
| Karen AkinsanyaOfficer | sold | 21,599at $30.00 | 17 Sep 2026filed 21 Sep 2026 |
| Rachit JainEVP & CFO | sold | 875at $15.60 | 16 Jul 2026filed 17 Jul 2026 |
| Ramy FaridPresident & CEO | sold | 43,000at $12.21 | 17 Apr 2026filed 17 Apr 2026 |
| Ramy FaridPresident & CEO | sold | 43,000at $12.33 | 16 Apr 2026filed 17 Apr 2026 |
| Rachit JainEVP & CFO | sold | 844at $12.75 | 16 Apr 2026filed 17 Apr 2026 |
| Jenny HermanCAO | sold | 608at $12.84 | 6 Mar 2026filed 6 Mar 2026 |
| Karen AkinsanyaOfficer | sold | 1,366at $12.90 | 5 Mar 2026filed 6 Mar 2026 |
| Ramy FaridPresident & CEO | sold | 3,661at $12.91 | 5 Mar 2026filed 6 Mar 2026 |
| Kenneth Patrick LortonEVP, CTO & COO, Software | sold | 1,222at $12.90 | 5 Mar 2026filed 6 Mar 2026 |
| Yvonne TranEVP, CLO & CPO | sold | 1,094at $12.90 | 5 Mar 2026filed 6 Mar 2026 |
| Jenny HermanCAO | sold | 775at $12.85 | 5 Mar 2026filed 6 Mar 2026 |
Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.
Institutions
Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.
| Manager | Shares | Change |
|---|---|---|
| BlackRock, Inc.added · filed 7 Aug 2026 | 10,521,724$171.0M | +843,164+8.7% |
| GATES FOUNDATION TRUSTunchanged · filed 14 Aug 2026 | 6,981,664$113.5M | 00.0% |
| Rubric Capital Management LPadded · filed 14 Aug 2026 | 6,400,000$104.0M | +400,000+6.7% |
| VANGUARD PORTFOLIO MANAGEMENT LLCreduced · filed 13 Aug 2026 | 3,787,391$61.5M | -74,806−1.9% |
| Sumitomo Mitsui Trust Group, Inc.reduced · filed 30 Jul 2026 | 2,706,143$44.0M | -484,694−15.2% |
| Amova Asset Management Americas, Inc.reduced · filed 13 Aug 2026 | 2,706,143$43.9M | -484,694−15.2% |
| VANGUARD CAPITAL MANAGEMENT LLCadded · filed 13 Aug 2026 | 2,691,149$43.7M | +86,775+3.3% |
| STATE STREET CORPadded · filed 7 Aug 2026 | 2,298,338$37.3M | +106,911+4.9% |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLCreduced · filed 13 Aug 2026 | 2,221,485$36.1M | -438,798−16.5% |
| ARK Investment Management LLCadded · filed 14 Aug 2026 | 2,154,018$35.0M | +86,883+4.2% |
Everyone who traded it
Same industry
Government contracts
From its SEC filings
Analyst forecasts
No analyst forecasts yet.